logo

Clinical Trial Calendar

Share
Company Name Axovant Sciences Ltd.
Event Name Topline data from phase 2b study of Intepirdine (HEADWAY)
Indication Dementia with Lewy bodies
Outcome Date 01/08/2018
Outcome Study fails; Results reported on Jan.8, 2018; Shares plunge over 48% in pre-mkt
Result Date Jan 2018
News
https://finance.yahoo.com/news/axovant-announces-negative-results-intepirdine-120000257.html
Return to Clinical Trial Calendar